alexa Strengthening Directly Observed Treatment for Tuberculosis in India | OMICS International
ISSN: 0974-8369
Biology and Medicine
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Strengthening Directly Observed Treatment for Tuberculosis in India

Saurabh RamBihariLal Shrivastava*, Prateek Saurabh Shrivastava and Jegadeesh Ramasamy

Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Kancheepuram, India

*Corresponding Author:
Dr. Saurabh RamBihariLal Shrivastava
3rd floor, Department of Community Medicine
Shri Sathya Sai Medical College & Research Institute
Ammapettai village
Thiruporur -Guduvancherry Main Road
Sembakkam Post, Kancheepuram -603108
Tamil Nadu, India
Tel: +919884227224
E-mail: [email protected]

Received October 27, 2015; Accepted October 30, 2015; Published Novemebr 07, 2015

Citation: Shrivastava SR, Shrivastava PS, Ramasamy J (2015) Strengthening Directly Observed Treatment for Tuberculosis in India. Biol Med (Aligarh) 8:e122. doi: 10.4172/0974-8369.1000e122

Copyright: © 2015 Shrivastava SR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Biology and Medicine



The findings of the Global Tuberculosis report – 2014 has revealed that out of the 9 million people who contracted the tuberculosis (TB) disease in the year 2013 worldwide, India alone accounted for more than one-quarter of the cases [1]. In-fact, India is also in the forefront with respect to drug-resistant TB (DR-TB) cases [1]. The trends clearly suggest that the national stakeholders have failed to accomplish the Millennium Development Goal-6 [1,2].

Directly observed treatment (DOT) strategy has been advocated to improve the treatment outcome [2,3]. In the execution of Directly Observed Treatment (DOT), a DOT provider (trained health worker/ trained community volunteer except family member of the patient) ensures and supports the patient in consuming their drugs throughout the duration of treatment [2,3]. Documented evidence is available to confirm that a major fraction of patients who do not receive DOT, stop their medicine once their symptoms subside [1,2]. This interruption in treatment not only results in the aggravation of the problem of antibiotic resistance, but also facilitates the transmission of DR-TB to their contacts [1,2]. Thus, implementation of DOT strategy is a crucial step in overcoming non-compliance to treatment as it is extremely hard to anticipate patients who will default over the course of their treatment [2,3]. In-fact, research performed in heterogeneous settings has shown that compliance with DOT strategy has resulted in a reduction in the number of cases of microbiologic failure, relapse, and acquired drug resistance; decrease in mortality rates; early detection of adverse effects, drug intolerance; and improvement in the quality of life of the patient and their family members [4-6]. In addition, poor treatment outcomes have been observed in settings where DOT strategy has not been followed [2,7].

One of the national health survey conducted in India showed that close to three-fourth of the nation’s population prefers private sector (viz. owing to the inherent flaws in the public health sector like strict timings of government healthcare establishments; geographical inaccessibility of government health care institutes; lack of availability of trained health care providers in remote areas; social stigma associated with the disease; and prevalent myths and misconceptions) for their ailments, owing to which most of them eventually land up in a non- DOT regimen [1,3,7,8].

Realizing the key role of private and non-governmental organizations in augmenting the health indicators of the country, a new scheme has been proposed, in which any DOT provider willing to undertake the initial home visit for address verification, administer treatment, and defaulter retrieval for missed doses will be given an honorarium for every patient who has completed treatment [9]. To further expand the benefits of DOT strategy, the policy makers have suggested to develop a comprehensive streetwise DOT directory; build partnerships with professional organizations/non-governmentalorganization; need-based execution of awareness activities targeted to appropriate audience; sensitization sessions for private medical practitioners to adhere to the diagnostic/treatment guidelines; encouragement of health care providers/community volunteers to become DOT providers; adequate counseling of the patients regarding the nature/duration/need of adherence and completion of treatment; ensuring immediate release of honorarium by the program managers /District Tuberculosis Officers to acknowledge the support of DOT providers towards the program; and ensuring monitoring of the DOT provider and guiding them appropriately [1,2,5,9]. In conclusion, the directly observed treatment in TB ensures long-term adherence to the treatment, and thus can play a significant role in improving the treatment indicators across the country.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

  • Annual congress on Research and Innovations in Medicine
    October 15-16, 2018 Seoul, South Korea

Article Usage

  • Total views: 8587
  • [From(publication date):
    January-2016 - Jul 23, 2018]
  • Breakdown by view type
  • HTML page views : 8316
  • PDF downloads : 271

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry


[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7